MedTrace Logo

Detection of High Expression Levels of EMT-Transcription Factor mRNAs in Patients With Pancreatic Cancer and Their Diagnostic Potential

NCT04323917 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 850

Last updated 2020-08-10

No results posted yet for this study

Summary

The present study is aimed at detecting and measuring mRNA levels of genes involved in epithelial to mesenchymal transition (EMT) in biological samples, i.e. in peripheral blood samples of pancreatic cancer (PC) patients and healthy controls, to determine the presence of disease, its progression and risk of recurrence.

Conditions

Interventions

DIAGNOSTIC_TEST

Liquid biopsy

Detection and quantification of EMT-transcription factor mRNA levels in blood

Sponsors & Collaborators

  • IRCCS San Raffaele

    collaborator OTHER

  • Istituto Clinico Humanitas

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-11-02
Primary Completion
2021-11-30
Completion
2022-11-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04323917 on ClinicalTrials.gov